Cardio-Oncology

Explore how to mitigate the effects of cancer on the heart.

Science News

Speckle-Tracking Strain Echocardiography for the Assessment of Left Ventricular Structure and Function
Revisiting the Open Vein Hypothesis to Reduce the Postthrombotic Syndrome: Implications for Multidisciplinary Care and Research
Palliative Care and Advanced Cardiovascular Disease in Adults
Risk-Based Primary Prevention of Heart Failure
Cardiovascular Toxicity in Patients Treated for Childhood Cancer

Journals

Premature Depolarizations and Overdue Questions: Unmet Needs in PVC Cardiomyopathy Research
Not All Prognostic Tools Are Equal: A Sex-Specific Approach to ASCVD Primary Prevention
Response by Abdel-Qadir et al to Letter Regarding Article, “Bleeding and New Malignancy Diagnoses After Anticoagulation for Atrial Fibrillation: A Population-Based Cohort Study”
Response by Patel and Giugliano to Letter Regarding Article, “Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation”
When Diagnostic Criteria Redefine Disease: Lessons From the Padua and European Task Force Criteria
The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.

The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.

CEO Nancy Brown on Cardio Oncology

CEO Nancy Brown explains why the AHA is funding a Strategically Focused Research Network on cardio-oncology with $15 million and, working with CancerLinQ LLC, making oncology datasets available on a version of the Precision Medicine Platform.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership